>GLEPIHLP_00001 putative type I restriction enzymeP M protein
MSITEKQRQQQAELHKKLWSIANDLRGNMDASEFRNYILGLIFYRFLSEKAEQEYADALS
GEDITYQEAWADEEYREDLKAELIDQVGYFIEPQDLFSAMIREIETQDFDIEHLATAIRK
VETSTLGEESENDFIGLFSDMDLSSTRLGNNVKERTALISKVMVNLDDLPFVHSDMEIDM
LGDAYEFLIGRFAATAGKKAGEFYTPQQVSKILAKIVTDGKDKLRHVYDPTCGSGSLLLR
VGKETQVYRYFGQERNNTTYNLARMNMLLHDVRYENFDIRNDDTLENPAFLGHTFDAVIA
NPPYSAKWTADSKFENDERFSGYGKLAPKSKADFAFIQHMVHYLDDEGTMAVVLPHGVLF
RGAAEGVIRRYLIEEKNYLEAVIGLPANIFYGTSIPTCILVFKKCRQQDDNVLFIDASND
FEKGKNQNHLSDAQVDRIIATYKRKETIDKYSYSATLQEIADNDYNLNIPRYVDTFEEEE
PIDLDQVQQDLKNIDKEIAEIEQEINAYLKELGVLKDE
>GLEPIHLP_00002 Staphylococcal superantigen-like 10
MKLTALAKATLALGILTTGTLTTEAYSGHAKQNQKSVNKHDKEALHRYYSGNFKEMKNIN
ALRHGKNNLRFKYRGMKTQVLLPGDEYRKYQQRRHTGLDVFFVQEKRDKHDISYTVGGVT
KSNKTPGFVSAPLLNVTKENGEDAFVKGYPYDIKKEEISLKELDFKLRKHLIEKYGLYKT
KSKDGKIKINLKDGSFYNLDLRSKLKFKHMGEVIDSKQIKDIEVNLK
>GLEPIHLP_00003 Staphylococcal superantigen-like 7
MKLTALAKATLALGILTTGVFTAESKAVHAKVELDETQRKYYIYMLKDYYSEESYEPTNI
SVKSEDYYGSNVLNFNHRNKNFKVFLLGDDKNKYKEKTHGLDVFAVPELIDTKGGIYSVG
GITKKNVRPVFGCVSHPGLLVKKIDPKHGFSVNELFFIQKEEVSLKELDFKIRKMLVEKY
RLYKGASDKGRIVINMKDEKKYVIDLSEKLSFDRMFDVMDSKQIKNIEVNLN
>GLEPIHLP_00004 Staphylococcal superantigen-like 7
MKLKTLAKATLALGLLTTGVITSEGQAVKAAEKQERVQHLHDIRDLHRYYSAPSFEYSNI
SGKVENYNGSNVVRFNQKDQNHQLFLLGKDKEEYKEGLQGQNVFVVQELIDPNGRLSTVG
GVTKNNNKTSETKTQLVVNKVDGGDLHASIDSFLIQKEEISLKELDFKIRQQLVNNYGLY
KGTSKYGKIIINLKDENKVEIDLSDKLQFERMGDVLNSKDIRGIAVTINQI
>GLEPIHLP_00005 Staphylococcal superantigen-like 5
MKIRTIVKASLALSILATGVITSTAQTVNASEHEAKYENVTKDIFDLRDYYSGESKALKN
VIGYHYSKGGRHYLVIDKNRKFTRVQIFGKDIERFKARKNPGLDIFVVKEAENRNGTVYS
YGGVTKKNQGAYYDYINAPRFQIKRDEGDGIATYGRVHYIYKEEVSLKELDFKLRQYLIQ
NFDLYKKFPKDSKIKVIMKDGGYYTFELNKKLQTNRMSDVIDGRNIEKIEANIR
>GLEPIHLP_00006 Staphylococcal superantigen-like 3
MKIRTIAKASLALGLVTTGASIVTTQSANAEVASALKAGQLAKINVSSSAVTTTTQAVNA
EQNRTANTEQASKSNTEKVSTSPSIKTEQTPKSNTQKATQPTPSGTTQPLPNAQPQSPQS
TPNASTSPSSSVETQQPQSPTTKQAQKEINPKYKDLRTYYTKPSLEFEKQFGFMLKPWTT
VRFMNVIPDWFIYKIALVGKDDKKYKDGPYDNIDVFIVLEDNKYQLKKYSVGGITKTNSK
KVDHKARISITKEDEKGKISRDDSEYKITKEEISLKELDFKLRKQLIEQHNLYGNIGSGT
IVIKTKNGGKYTFELHKKLQEHRMADVIDGTSIDRIEVNLKSS*WILHRTYERCAEKLSD
NYLHVAQLLSCCAVI
>GLEPIHLP_00007 Staphylococcal superantigen-like 4
MKMKSIAKVSLVLGILATGVNTVTEQPVHAENKPIQVSQNSKNLKAYYTQPSVEYKNVTG
YISSIQPKAGTKFMNIIEGNTVNNLALVGKDKQHYHTGVHRNLDIFYVNEDKRFEGSKYS
IGGITEASDKAVDQIAEARVIKEDHTGEYDYDFFPFKIDKEAMTLKEVDFKIRKHLIDHY
GLYGEMSSGTVTVKMKYYGKYTFELDKKLQEDRMADIIKVTDIDRIEVIVKKA
>GLEPIHLP_00008 Staphylococcal superantigen-like 1
MKFKAIAKASLALGMLATGVITSNVQSVQAKAEVKQQSEADLKLYYSGPSFEYKKVTGYG
FVEGKDRFIDFIYNGQYNKISLVGSDKDKYNEEVNPDIDVFVVREGNGRQADNHSIGGVT
KTNRGVYYDYIHTPILEIKKGKEEPQSSLYQIYKEDISLKELDYRLRERAIKHHGLYSKG
LKQGQITITMNDGTTHTIDLSQKLEKERMGQSVDGKQIQKILVEMK
>GLEPIHLP_00009 Quinone oxidoreductase 2
MNIMLTGATGHLGTHITNQAIANHIDHFHIGVRNVEKVPEDWRGKVSVRQLDYFNQESMV
EAFKGMDTVVFIPSIIHPSFKRIPEVENLVYAAKQCGVAHIIFIGYYADQHNNPFHMSPY
FGYAARLLATSGIDYTYVRMAMYMDPLKPYLPELMNMHKLIYPAGDGRINYITRNDIARG
VIAIIKNPDTWGKCYLLSGYSYDMKELAAILSEASGTEIKYEPVSLETFAKMYDEPKGFG
ALLASMYDAGARGLLDQESNDFQQLVNDQPQTLQSFLQENI
>GLEPIHLP_00010 hypothetical protein
MNIISIILIIFVALEFFYIMYLETIATTSKKTSETFNISVDKLKDKNINVLLKNQGVYNG
LIGVLLIYGLFISSNPKEICAAILVYIIGVAIYGGLSSNISIFFKQGTLPVLALISMLW
